These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24874401)

  • 21. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae.
    Gulle H; Schoel B; Chiplunkar S; Gangal S; Deo MG; Kaufmann SH
    Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):44-53. PubMed ID: 1602193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy.
    Reece ST; Ireton G; Mohamath R; Guderian J; Goto W; Gelber R; Groathouse N; Spencer J; Brennan P; Reed SG
    Clin Vaccine Immunol; 2006 Mar; 13(3):333-40. PubMed ID: 16522774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgG subclass distribution of antibody responses to protein and polysaccharide mycobacterial antigens in leprosy and tuberculosis patients.
    Sousa AO; Henry S; Marója FM; Lee FK; Brum L; Singh M; Lagrange PH; Aucouturier P
    Clin Exp Immunol; 1998 Jan; 111(1):48-55. PubMed ID: 9472660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early detection of leprosy by examination of household contacts, determination of serum anti-PGL-1 antibodies and consanguinity.
    Bazan-Furini R; Motta AC; Simão JC; Tarquínio DC; Marques W; Barbosa MH; Foss NT
    Mem Inst Oswaldo Cruz; 2011 Aug; 106(5):536-40. PubMed ID: 21894372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential role of B7-1 and CD28 molecules in immunosuppression in leprosy.
    Agrewala JN; Kumar B; Vohra H
    Clin Exp Immunol; 1998 Jan; 111(1):56-63. PubMed ID: 9472661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
    Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
    Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of Mycobacterium leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen and recombinant interleukin 2.
    Kaplan G; Sampaio EP; Walsh GP; Burkhardt RA; Fajardo TT; Guido LS; de Miranda Machado A; Cellona RV; Abalos RM; Sarno EN
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6269-73. PubMed ID: 2668961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to ICRC-in, an antigen from cultivable acid-fast bacilli from M. leprae isolated from lepromatous nodules.
    Bapat CV; Modak MS; DeSouza NG; Chulawalla RG
    Lepr India; 1977 Oct; 49(4):472-84. PubMed ID: 342823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sero-immunoreactivity of cloned protein antigens of Mycobacterium leprae.
    Khan MB; Deshpande RG; Davidson SK; Navalkar RG
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):195-200. PubMed ID: 1522362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure to induce delayed-type hypersensitivity to Mycobacterium leprae in long-term treated lepromatous leprosy patients.
    Smelt AH; Rees RH; Liew FY
    Clin Exp Immunol; 1981 Jun; 44(3):507-11. PubMed ID: 7035031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?
    Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leprosy reactions: humoral and cellular immune responses to M. leprae, 65kDa, 28kDa, and 18 kDa antigens.
    Mohanty KK; Joshi B; Katoch K; Sengupta U
    Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):149-58. PubMed ID: 15301588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A method for the detection of M. leprae antigens in urine of leprosy patients by gel diffusion and gel electrophoretic techniques and significance in diagnosis.
    Patil SA; Katoch K; Sengupta U
    Acta Leprol; 1991; 7(5):403-7. PubMed ID: 1805496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of skin test with M. leprae soluble antigen on reaction to a subsequent test with the same antigen.
    Gupte MD; Vallishayee RS; Anantharaman DS; Kannan S
    Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):54-60. PubMed ID: 1602194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presence of human T-cell responses to the Mycobacterium leprae 45-kilodalton antigen reflects infection with or exposure to M. leprae.
    Macfarlane A; Mondragon-Gonzalez R; Vega-Lopez F; Wieles B; de Pena J; Rodriguez O; Suarez y de la Torre R; de Vries RR; Ottenhoff TH; Dockrell HM
    Clin Diagn Lab Immunol; 2001 May; 8(3):604-11. PubMed ID: 11329466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of a whole blood assay to monitor the immune response to mycobacterial antigens in leprosy patients: a predictor for type 1 reaction onset?
    Weir RE; Butlin CR; Neupane KD; Failbus SS; Dockrell HM
    Lepr Rev; 1998 Sep; 69(3):279-93. PubMed ID: 9805883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demonstration of mycobacterial antigens in nerve biopsies from leprosy patients using peroxidase-antiperoxidase immunoenzyme technique.
    Mshana RN; Humber DP; Harboe M; Belehu A
    Clin Immunol Immunopathol; 1983 Dec; 29(3):359-68. PubMed ID: 6416726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is PGL-1 also present in Leishmania donovani promastigotes?
    Gupta PN; Pal NK
    Indian J Lepr; 1998; 70(2):161-4. PubMed ID: 9724851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
    Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serological response in leprosy and tuberculosis patients to the 18-kDa antigen of Mycobacterium leprae and antigen 85B of Mycobacterium bovis BCG.
    Vikerfors T; Olcén P; Wiker H; Watson JD
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):571-80. PubMed ID: 8151188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.